Home›People›James McCollum
JM

James McCollum

Director at Lenz Therapeutics.

ExecutiveDirectorPublic company
Updated Nov 2, 2026·Latest SEC filing Jun 15, 2026·Suggest an edit

About James McCollum

James McCollum is a director at Lenz Therapeutics.

James McCollum reports to the SEC as a director of 1 public company.

James McCollum first appears on SEC filings in 2016.

Experience

This experience comes from SEC filings. The years are when the filings name James McCollum in the role, so the role may have started earlier or lasted longer.

Lenz Therapeutics, Inc.
Director
2016 – 2026 · Public company (LENZ)

Key Colleagues at Startups

The people James McCollum works with at each company, as listed on that company's latest Form D.

Lenz Therapeutics, Inc. · Form D, Mar 10, 2023
ES
Evert Schimmelpennink
President & CEO, director
CO
Clare Ozawa
Director
ZS
SL

Sources

  1. SECLenz Therapeutics, Inc. Form D, filed Mar 10, 2023
  2. SECForms 3, 4 and 5 filed by James McCollum (SEC filer 1200889)